Accepted at 7:51 p.m. Oct, 10, 2024 by Stapedius
Author: alexlewis
Related Note: 1684241642856
Rationale for change

Q&A, +tags

Text Text
Extra
In the short term, they modestly improve or stabilise cognition, alertness and function. All acetylcholinesterase inhibitors appear to have similar efficacy for Alzheimer dementia Before starting an acetylcholinesterase inhibitor, perform an electrocardiogram (ECG), record the patient’s weight and assess their falls risk

If inadequate treatment or acetylcholinerase inhibitors cannot be used add/use memantine

American resources might recommend vitamin E. eTG clearly states to avoid vitamin E due to the association with increased mortality
Personal Notes
Empty field
Missed Questions
Empty field
Oxford Handbook
Empty field
First Aid
Empty field
AMBOSS
Empty field
eTG Complete
Talley & O'Connor
Empty field
Additional Resources
Empty field
Source
eTG Topic: Dementia Published March 2021 Accessed 16 May 2023
One by one
Empty field
Changed Tags
#Malleus_CM::#eTG_Complete::Psychotropic::Dementia #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Geriatric_Medicine #Malleus_CM::#Pharmacology::16_Neurological_drugs::04_Drugs_for_Alzheimer’s_disease::01_Anticholinesterases_in_Alzheimer’s_disease::Donepezil::03_Indications #Malleus_CM::#Pharmacology::16_Neurological_drugs::04_Drugs_for_Alzheimer’s_disease::01_Anticholinesterases_in_Alzheimer’s_disease::Galantamine::03_Indications #Malleus_CM::#Pharmacology::16_Neurological_drugs::04_Drugs_for_Alzheimer’s_disease::01_Anticholinesterases_in_Alzheimer’s_disease::Rivastigmine::03_Indications
#Malleus_CM::#Subjects::Neurology_&_Ophthalmology::10_Degenerative_Disorders::Alzheimer_Disease::10_Management #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Neurology #Malleus_CM::#Resources_by_Rotation::Psychiatry #Malleus_CM::#Subjects::Psychiatry::06_Delirium_&_Dementia::Dementia::10_Management